cepharanthine has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobuchi, H; Li, MJ; Matsuno, T; Utsumi, K; Yasuda, T | 1 |
Akiyama, S; Hagino, Y; Kobayashi, M; Kohno, K; Kuwano, M; Shimada, T; Shiraishi, N | 1 |
2 other study(ies) available for cepharanthine and epidermal growth factor
Article | Year |
---|---|
Inhibition of neutrophil priming and tyrosyl phosphorylation by cepharanthine, a nonsteroidal antiinflammatory drug.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Annexin A1; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Epidermal Growth Factor; Granulocyte Colony-Stimulating Factor; Humans; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Respiratory Burst; Tumor Necrosis Factor-alpha | 1992 |
Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
Topics: ADP Ribose Transferases; Alkaloids; Bacterial Toxins; Benzylisoquinolines; Cell Survival; Drug Synergism; Epidermal Growth Factor; Exotoxins; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Pseudomonas aeruginosa Exotoxin A; Tissue Distribution; Virulence Factors | 1988 |